The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Open accessAbstract
Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible for hospital-acquired nosocomial infections in the modern healthcare system. Due to the prevalence of infections and outbreaks caused by multi-drug resistant A. baumannii, few antibiotics are effective for treating infections caused by this pathogen. To overcome this problem, knowledge of the pathogenesis and antibiotic resistance mechanisms of A. baumannii is important. In this review, we summarize current studies on the virulence factors that contribute to A. baumannii pathogenesis, including porins, capsular polysaccharides, lipopolysaccharides, phospholipases, outer membrane vesicles, metal acquisition systems, and protein secretion systems. Mechanisms of antibiotic resistance of this organism, including acquirement of -lactamases, up-regulation of multidrug efflux pumps, modification of aminoglycosides, permeability defects, and alteration of target sites, are also discussed. Lastly, novel prospective treatment options for infections caused by multi-drug resistant A. baumannii are summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–292 of 292
Umland, T. C., Schultz, L. W., MacDonald, U., Beanan, J. M., Olson, R., & Russo, T. A. (2012) · mBio · doi:10.1128/mbio.00113-12 · Cited by 80
Harding, C. M., Kinsella, R. L., Palmer, L. D., Skaar, E. P., & Feldman, M. F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005391 · Cited by 79
Pantopoulou, A., Giamarellos‐Bourboulis, E. J., Raftogannis, M., Τσαγανός, Θ., Dontas, I. A., Koutoukas, P., Baziaka, F., Giamarellou, H., & Perrea, D. N. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.009 · Cited by 77
Juttukonda, L. J., Chazin, W., & Skaar, E. P. (2016) · mBio · doi:10.1128/mbio.01475-16 · Cited by 76
Santimaleeworagun, W., Wongpoowarak, P., D, P. C. M., Pattharachayakul, S., Tansakul, P., & Garey, K. W. (2011) · PubMed · Cited by 75
Controlling Mutation: Intervening in Evolution as a Therapeutic Strategy
Cirz, R. T., & Romesberg, F. E. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701597741 · Cited by 74
Jeon, J., Ryu, C., Lee, J.-Y., Park, J., Yong, D., & Lee, K. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00526-16 · Cited by 74
Self-citationZhang, X., Yang, T., Cao, J., Sun, J., Dai, W., & Zhang, L. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.04.019 · Cited by 73
Rodríguez‐Rubio, L., Chang, W.-L., Gutiérrez, D., Lavigne, R., Martı́nez, B., Rodrı́guez, A., Govers, S. K., Aertsen, A., Hirl, C., Biebl, M., et al. (2016) · Scientific Reports · doi:10.1038/srep35382 · Cited by 73
Atrouni, A. A., Hamzé, M., Jisr, T., Lemarié, C., Eveillard, M., Joly‐Guillou, M., & Kempf, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.09.017 · Cited by 72
Bae, S., Kim, M., Park, S., Kim, H. S., Sung, H., Kim, M., Kim, S., Lee, S., Choi, S., Woo, J. H., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00839-16 · Cited by 72
Self-citationPérez, A., Merino, M. V., Rumbo‐Feal, S., Álvarez-Fraga, L., Vallejo, J. A., Beceiro, A., Ohneck, E. J., Mateos, J., Fernández‐Puente, P., Actis, L. A., et al. (2016) · Virulence · doi:10.1080/21505594.2016.1262313 · Cited by 72
Peck, K. R., Kim, M. J., Choi, J. Y., Kim, H. S., Kang, C., Cho, Y. K., Park, D. W., Lee, H. J., Lee, M. S., & Ko, K. S. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.036939-0 · Cited by 70
Fan, B., Guan, J., Wang, X., & Cong, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157757 · Cited by 69
Principe, L., Piazza, A., Giani, T., Bracco, S., Caltagirone, M. S., Arena, F., Nucleo, E., Tammaro, F., Rossolini, G. M., Pagani, L., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00291-14 · Cited by 68
Park, Y. K., & Ko, K. S. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-4498-5 · Cited by 67
Liao, Y., Kuo, S., Chiang, M., Lee, Y., Sung, W., Chen, Y.-H., Chen, T.-L., & Fung, C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01343-15 · Cited by 67
Asahara, T., Takahashi, A., Yuki, N., Kaji, R., Takahashi, T., & Nomoto, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02928-15 · Cited by 67
Elhosseiny, N. M., Amin, M. A., Yassin, A. S., & Attia, A. S. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.11.008 · Cited by 65
Tada, T., Miyoshi‐Akiyama, T., Shimada, K., Shimojima, M., & Kirikae, T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01212-13 · Cited by 65
Su, C.-H., Wang, J., Hsiung, C. A., Chien, L., Chi, C., Yu, H.-T., Chang, F., & Chang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037788 · Cited by 65
Lee, Y., Kim, C., Lee, H., Jeong, S. H., Yong, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01672-09 · Cited by 65
Konstantinidis, T. G., Kambas, K., Mitsios, A., Panopoulou, M. I., Tsironidou, V., Dellaporta, E., Kouklakis, G., Αραμπατζιόγλου, Α., Angelidou, I., Mitroulis, I., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02063-15 · Cited by 65
Kim, Y. J., Kim, S. I., Kim, Y. R., Hong, K., Wie, S., Park, Y. J., Jeong, H., & Kang, M. W. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811000744 · Cited by 64
Self-citationRisk factors for nephrotoxicity onset associated with polymyxin B therapy
Dubrovskaya, Y., Prasad, N., Lee, Y., Esaian, D., Figueroa, D. A., & Tam, V. H. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv014 · Cited by 63
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones
Rodríguez, C. H., Ambrosio, A. D., Bajuk, M., Spinozzi, M., Nastro, M., Bombicino, K. A., Radice, M. A., Gutkind, G., Vay, C. A., & Famiglietti, A. M. R. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.604 · Cited by 63
García‐Quintanilla, M., Carretero-Ledesma, M., Moreno-Martínez, P., Martín-Peña, R., Pachón, J., & McConnell, M. J. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.017 · Cited by 62
Li, Z., Zhang, R.-L., Bi, X., Xu, L., Fan, M., Xie, D., Xian, Y., Wang, Y., Li, X.-J., Wu, Z.-D., et al. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.03.009 · Cited by 60
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Feliu, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 59
Liu, D., Liu, Z., Hu, P., Cai, L., Fu, B., Li, Y., Lu, S., Liu, N., Ma, X., Chi, D., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.02.018 · Cited by 59
Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G., & Shamoo, Y. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140489 · Cited by 58
Schröder, W., Goerke, C., & Wolz, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks456 · Cited by 57
Kostoulias, X., Murray, G. L., Cerqueira, G. M., Kong, J. B., Bantun, F., Mylonakis, E. E., Khoo, C. A., & Peleg, A. Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01540-15 · Cited by 56
Li, X., Liu, L., Ji, J. S., Chen, Q., Hua, X., Jiang, Y., Feng, Y., & Yang, Y. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2272-y · Cited by 56
Arivett, B. A., Fiester, S. E., Ohneck, E. J., Penwell, W. F., Kaufman, C., Relich, R. F., & Actis, L. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01472-15 · Cited by 56
Kim, C., Lee, Y., Lee, H., Woo, G.-J., Song, W., Kim, M., Lee, W. G., Jeong, S. H., Lee, K., & Chong, Y. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.07.014 · Cited by 55
Identification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors
Blanchard, C. E., Barnett, P., Perlmutter, J. I., & Dunman, P. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03535-14 · Cited by 54
Vijayakumar, S., Gopi, R., Gunasekaran, P., Bharathy, M., Walia, K., Anandan, S., & Veeraraghavan, B. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0125-y · Cited by 54
Martinez, T., Martínez, I., Vázquez, G. J., Aquino, E. E., & Robledo, I. E. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000289 · Cited by 53
Traglia, G. M., Chua, K., Centrón, D., Tolmasky, M. E., & Ramirez, M. S. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu176 · Cited by 52
CipA ofAcinetobacter baumanniiIs a Novel Plasminogen Binding and Complement Inhibitory Protein
Koenigs, A., Stahl, J., Averhoff, B., Göttig, S., Wichelhaus, T. A., Wallich, R., Zipfel, P. F., & Kraiczy, P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv601 · Cited by 51
Tsuji, B. T., Landersdorfer, C. B., Lenhard, J. R., Cheah, S.-E., Thamlikitkul, V., Rao, G. G., Holden, P. N., Forrest, A., Bulitta, J. B., Nation, R. L., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02831-15 · Cited by 51
Potron, A., Poirel, L., Croizé, J., Chanteperdrix, V., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-08 · Cited by 50
Yılmaz, E. M., Sünbül, M., Aksoy, A., Yılmaz, H., Güney, A. K., & Güvenç, T. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.06.003 · Cited by 50
Higgins, P. G., Janßen, K., Fresen, M. M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01759-12 · Cited by 48
Stress Response and Virulence Functions of the Acinetobacter baumannii NfuA Fe-S Scaffold Protein
Zimbler, D. L., Park, T. M., Arivett, B. A., Penwell, W. F., Greer, S. M., Woodruff, T. M., Tierney, D. L., & Actis, L. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00213-12 · Cited by 47
Yamamoto, M., Nagao, M., Matsumura, Y., Matsushima, A., Ito, Y., Takakura, S., & Ichiyama, S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr336 · Cited by 46
Yang, Y., Lee, Y., Tseng, K.-C., Huang, W., Chuang, M.-F., Kuo, S., Lauderdale, T.-L. Y., & Chen, T.-L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02994-15 · Cited by 46
Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein
Koenigs, A., Zipfel, P. F., & Kraiczy, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134418 · Cited by 45
Traglia, G. M., Quinn, B., Schramm, S. T. J., Soler‐Bistué, A., & Ramirez, M. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00529-16 · Cited by 45
Trebosc, V., Gartenmann, S., Royet, K., Manfredi, P., Tötzl, M., Schellhorn, B., Pieren, M., Tigges, M., Lociuro, S., Sennhenn, P. C., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-16 · Cited by 45
Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System
Ruiz, F. M., Santillana, E., Spínola‐Amilibia, M., Torreira, E., Culebras, E., & Romero, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129691 · Cited by 44
Liu, Q., Li, W., Feng, Y., & Tao, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098091 · Cited by 44
Bonin, R. F., Chapeaurouge, A., Perales, J., da Silva, J. G., Nascimento, H. J., Carvalho-Assef, A. P. D., & Senna, J. P. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300133 · Cited by 44
Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from Haiti
Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T., & Poirel, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05124-11 · Cited by 44
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate
Al-Agamy, M. H., Jeannot, K., El-Mahdy, T. S., Shibl, A. M., Al-Kattan, W., Plésiat, P., & Courvalin, P. M. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0152 · Cited by 44
Lee, C., Lee, J. H., Park, K. S., Jeong, B. C., & Lee, S. H. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00828 · Cited by 43
Self-citationRao, G. G., Ly, N. S., Bulitta, J. B., Soon, R. L., Roman, M. D. S., Holden, P. N., Landersdorfer, C. B., Nation, R. L., Li, J., Forrest, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw293 · Cited by 43
Phee, L. M., Betts, J. W., Bharathan, B., & Wareham, D. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00753-15 · Cited by 42
Mosqueda, N., Espinal, P., Cosgaya, C., Viota, S., Plasensia, V., Álvarez-Lerma, F., Montero, M., Gómez, J., Horcajada, J. P., Vilà, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-13 · Cited by 42
Moland, E. S., Craft, D. W., Chong, Y., Kim, S.-Y., Hachmeister, L., Sayed, S. D., & Thomson, K. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-07 · Cited by 41
Fernando, D. M., & Kumar, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr519 · Cited by 40
Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii
Shin, B., & Park, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137751 · Cited by 40
Chung, J.-H., Bhat, A., Kim, C., Yong, D., & Ryu, C. (2016) · Scientific Reports · doi:10.1038/srep28168 · Cited by 40
Ali, H. M., Salem, M. Z. M., Elshikh, M. S., Abdel‐Megeed, A., Alogaibi, Y. A., & Talea, I. A. (2016) · Journal of AOAC International · doi:10.5740/jaoacint.16-0139 · Cited by 40
Bakour, S., Alsharapy, S. A., Touati, A., & Rolain, J. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0018 · Cited by 39
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis
Fulnecky, E. J., Wright, D., Scheld, W. M., Kanawati, L., & Shoham, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.003 · Cited by 39
Principe, L., Capone, A., Mazzarelli, A., et al. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0250 · Cited by 38
IS CR2 , Another Vehicle for bla VEB Gene Acquisition
Poirel, L., Mugnier, P. D., Toleman, M. A., Walsh, T. R., Rapoport, M., Petroni, A., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00414-09 · Cited by 38
Parra-Millán, R., Me, J.-M., Sánchez-Encinales, V., Ayerbe-Algaba, R., Gutiérrez‐Valencia, A., Pachón-Ibáñez, M. E., Díaz, C., del Palacio, J. P., López-Cortés, L. F., Pachón, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02708-15 · Cited by 38
Jaruratanasirikul, S., Wongpoowarak, W., Wattanavijitkul, T., Sukarnjanaset, W., Samaeng, M., Nawakitrangsan, M., & Ingviya, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01669-16 · Cited by 37
Development of Colistin-DependentAcinetobacter baumannii-Acinetobacter calcoaceticusComplex
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01115-07 · Cited by 35
Elhosseiny, N. M., El‐Tayeb, O. M., Yassin, A. S., Lory, S. J., & Attia, A. S. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.09.006 · Cited by 34
Rumbo, C., Vallejo, J. A., Cabral, M. P., Martínez-Guitián, M., Pérez, A., Beceiro, A., & Bou, G. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw342 · Cited by 33
Lipid A Biosynthesis of Multidrug-Resistant Pathogens - A Novel Drug Target
Lee, C., Lee, J. H., Jeong, B. C., & Lee, S. H. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990494 · Cited by 32
Self-citationSrinivasan, V. B., Venkataramaiah, M., Mondal, A., & Rajamohan, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141314 · Cited by 31
Li, Y., Guo, Q., Wang, P., Zhu, D., Ye, X., Wu, S., & Wang, M. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.04.005 · Cited by 29
Li, X., Quan, J., Yang, Y. F., Ji, J. S., Liu, L., Fu, Y., Hua, X., Chen, Y., Pi, B., Jiang, Y., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2674-0 · Cited by 29
Aranda, J., López-Martín, M., Leiva, E., Magán, A., Adler, B., Bou, G., & Barbé, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02346-13 · Cited by 28
He, S., He, H., Chen, Y., Chen, Y., Wang, W., & Yu, D. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00507 · Cited by 27
Li, L., Hassan, K. A., Brown, M. H., & Paulsen, I. T. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv460 · Cited by 25
Cirioni, O., Simonetti, O., Pierpaoli, E., Barucca, A., Ghiselli, R., Orlando, F., Pelloni, M., Trombettoni, M. M. C., Guerrieri, M., Offidani, A., et al. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.010 · Cited by 25
Davison, M. R., Treangen, T. J., Koren, S., Pop, M., & Bhaya, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160574 · Cited by 24
Sakoulas, G., Rose, W. E., Berti, A. D., Olson, J., Munguia, J., Nonejuie, P., Sakoulas, E. M., Rybak, M. J., Pogliano, J., & Nizet, V. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01745-16 · Cited by 23
Hong, S. B., Shin, K. S., Ha, J., & Han, K. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.055384-0 · Cited by 19
Rodríguez, C. H., Nastro, M., Vay, C. A., & Famiglietti, A. M. R. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000147 · Cited by 18
Lenhard, J. R., Gall, J. S., Bulitta, J. B., Thamlikitkul, V., Landersdorfer, C. B., Forrest, A., Nation, R. L., Li, J., & Tsuji, B. T. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.024 · Cited by 17
Córdoba, J. P., Coronado-Álvarez, N. M., Parra, D., & Parra-Ruiz, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00493-15 · Cited by 12
Jara, L. M., Pérez−Varela, M., Corral, J., Arch, M., Cortés, P., Bou, G., Aranda, J., & Barbé, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01810-15 · Cited by 11
Chiu, C.-H., Liu, Y., Wang, Y.-C., Lee, Y., Kuo, S., Chen, T.-L., Lin, J., & Wang, F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw331 · Cited by 10
Muthusamy, D. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19968.8535 · Cited by 6
Nowak-Zaleska, A., Wieczór, M., Czub, J., Nierzwicki, Ł., Kotłowski, R., Mikucka, A., & Gospodarek, E. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.09.004 · Cited by 6
Cited by
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Chaturvedi, P., Shukla, P., Giri, B. S., Chowdhary, P., Chandra, R., Gupta, P., & Pandey, A. (2021) · Environmental Research · doi:10.1016/j.envres.2020.110664 · Cited by 709
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Kyriakidis, I., Vasileiou, E., Pana, Z. D., & Tragiannidis, A. (2021) · Pathogens · doi:10.3390/pathogens10030373 · Cited by 678
Ayoub Moubareck, C., & Hammoudi Halat, D. (2020) · Antibiotics · doi:10.3390/antibiotics9030119 · Cited by 627
Metadata
- Authors
- Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-13
- Volume
- 7
- Pages
- 55-55
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2594303706
- Cited by
- 1,016
- References
- 292
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.